Vor Biopharma (VOR)
Develops licensed telitacicept for autoimmune diseases outside Greater China.
$22.00
After hours+0.01 (+0.05%)
At close$21.99(+0.46%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 51 days
EPS estimate
−$0.81
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$8.80−$5.20−$251.20−$121.63$44.50−$0.73−$1.16Pending
Estimate−$0.34−$5.00−$11.40−$3.06−$1.14−$0.75−$0.86−$0.81
Surprise−2,488.2%−4.0%−2,103.5%−3,874.8%+4,003.5%+2.7%−35.4%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2029 | −$0.68 | — | — |
| Sep 2029 | −$0.74 | — | — |
| Jun 2029 | −$0.78 | — | — |
| Mar 2029 | −$0.83 | — | — |
| Dec 2028 | −$0.82 | — | — |
| Sep 2028 | −$0.80 | — | — |
| Jun 2028 | −$0.83 | — | — |
| Mar 2028 | −$0.81 | — | — |
| Dec 2027 | −$1.01 | — | — |
| Sep 2027 | −$0.98 | — | — |
| Jun 2027 | −$1.01 | — | — |
| Mar 2027 | −$0.94 | — | — |
| Dec 2026 | −$0.87 | — | — |
| Nov 2026 | −$0.81 | — | — |
| Aug 2026 | −$0.86 | −$1.16 | −35.4% |
| May 2026 | −$0.75 | −$0.73 | +2.7% |
| Mar 2026 | −$1.14 | $44.50 | +4,003.5% |
| Nov 2025 | −$3.06 | −$121.63 | −3,874.8% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2029 | −$0.68 | — | — | $15.9M | — | — | — |
| Sep 2029 | −$0.74 | — | — | $9.3M | — | — | — |
| Jun 2029 | −$0.78 | — | — | $4.2M | — | — | — |
| Mar 2029 | −$0.83 | — | — | $716.5K | — | — | — |
| Dec 2028 | −$0.82 | — | — | $0 | — | — | — |
| Sep 2028 | −$0.80 | — | — | $0 | — | — | — |
| Jun 2028 | −$0.83 | — | — | $0 | — | — | — |
| Mar 2028 | −$0.81 | — | — | $0 | — | — | — |
| Dec 2027 | −$1.01 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.98 | — | — | $0 | — | — | — |
| Jun 2027 | −$1.01 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.94 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.87 | — | — | $0 | — | — | — |
| Nov 12, 2026 | −$0.81 | — | — | $0 | — | — | — |
| Aug 11, 2026 | −$0.86 | −$1.16 | −35.4% | — | — | — | +0.9% |
| May 13, 2026 | −$0.75 | −$0.73 | +2.7% | — | — | — | −5.3% |
| Mar 30, 2026 | −$1.14 | $44.50 | +4,003.5% | — | — | — | +1.5% |
| Nov 13, 2025 | −$3.06 | −$121.63 | −3,874.8% | — | — | — | −3.1% |
| Aug 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 20, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 14, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 9, 2021 | |||||||
| May 6, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Dec 18, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |